Neurology Minute
Neurology Minute
American Academy of Neurology
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
2 minutes Posted Oct 3, 2023 at 8:30 am.
0:00
2:27
Download MP3
Show notes

Dr. Rae Bacharach discusses the paper, "Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis".

Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2806000